Skip to main content
Top
Published in: Clinical Rheumatology 2/2007

01-02-2007 | Original Article

MCTD: is it rare in India?

Authors: A. Lawrence, A. Aggarwal, R. Misra

Published in: Clinical Rheumatology | Issue 2/2007

Login to get access

Abstract

Mixed connective tissue disease (MCTD) has been rarely reported from India. Thus, we did a retrospective analysis of cases of MCTD seen at our hospital during the last 13 years. We found 16 cases among 441 patients with connective tissue disease. All the 16 patients (15 females) of MCTD fulfilled classification criteria by Kasukawa and at least one of the other two (Sharp’s and Alarcon-Sergovia). Raynaud’s phenomenon, sclerodactyly, puffy fingers, esophageal hypomotility, and pulmonary disease were the most common manifestations. At a median follow-up of 12 months (1–172), 12 patients developed features of limited scleroderma and three patients had pulmonary hypertension.
Literature
1.
go back to reference Sharp GC, Irwing W et al (1972) Mixed connective tissue disease an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen. Am J Med 52:148–162CrossRefPubMed Sharp GC, Irwing W et al (1972) Mixed connective tissue disease an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen. Am J Med 52:148–162CrossRefPubMed
2.
go back to reference Smolen JS, Steiner G (1998) Mixed connective tissue disease: to be or not to be? Arthritis Rheum 41:768–777CrossRefPubMed Smolen JS, Steiner G (1998) Mixed connective tissue disease: to be or not to be? Arthritis Rheum 41:768–777CrossRefPubMed
3.
go back to reference Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serological findings. Arthritis Rheum 42:899–900CrossRefPubMed Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serological findings. Arthritis Rheum 42:899–900CrossRefPubMed
4.
go back to reference Isenberg D, Black C (1999) Naming names! Comment on the article by Smolen and Steiner. Arthritis Rheum 42:191–192CrossRefPubMed Isenberg D, Black C (1999) Naming names! Comment on the article by Smolen and Steiner. Arthritis Rheum 42:191–192CrossRefPubMed
5.
go back to reference Gaudreau A, Amor B, Kahn MF, Ryckewaet A, Sany J, Peltier AP (1978) Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA). Ann Rheum Dis 37:321–327PubMed Gaudreau A, Amor B, Kahn MF, Ryckewaet A, Sany J, Peltier AP (1978) Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA). Ann Rheum Dis 37:321–327PubMed
6.
go back to reference Skriner K, Sommergruber WH, Tremmel V et al (1997) Anti-A2/RA33 autoantibodies are directed to the RNA region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex: differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus and mixed connective tissue disease. J Clin Invest 100:127–135PubMedCrossRef Skriner K, Sommergruber WH, Tremmel V et al (1997) Anti-A2/RA33 autoantibodies are directed to the RNA region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex: differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus and mixed connective tissue disease. J Clin Invest 100:127–135PubMedCrossRef
7.
go back to reference Barakat S, Briand JP, Abuaf N, van Regenmortel MH, Muller S (1991) Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera. Clin Exp Immunol 86:71–78PubMedCrossRef Barakat S, Briand JP, Abuaf N, van Regenmortel MH, Muller S (1991) Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera. Clin Exp Immunol 86:71–78PubMedCrossRef
8.
go back to reference Sharp GC (1987) Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam, pp 23–32 Sharp GC (1987) Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam, pp 23–32
9.
go back to reference Alarcon-Sergovia D, Villareal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam pp 33–40 Alarcon-Sergovia D, Villareal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam pp 33–40
10.
go back to reference Kasukawa R, Tojo T, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam pp 41–47 Kasukawa R, Tojo T, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam pp 41–47
11.
go back to reference Sood A, Kumar A, Pande I, Malaviya AN (1995) Does mixed connective tissue disease existin India? Br J Rheumatol 34:539–541PubMed Sood A, Kumar A, Pande I, Malaviya AN (1995) Does mixed connective tissue disease existin India? Br J Rheumatol 34:539–541PubMed
12.
go back to reference Nedumaran, Rajendran CP, Porkodi R, Parthiban R (2001) Mixed connective tissue disease—clinical and immunological profile. JAPI 49:412–414PubMed Nedumaran, Rajendran CP, Porkodi R, Parthiban R (2001) Mixed connective tissue disease—clinical and immunological profile. JAPI 49:412–414PubMed
Metadata
Title
MCTD: is it rare in India?
Authors
A. Lawrence
A. Aggarwal
R. Misra
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0276-4

Other articles of this Issue 2/2007

Clinical Rheumatology 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.